로딩 중…
지수 로딩 중…
Standard BioTools Inc.
LAB· NASDAQ· Health Care· Health Care Equipment & Services
$0.87-0.21%
2026-08-03
Financials
Valuation Metrics
Standard BioTools Inc.'s Market Cap is $338M. At end of 2025 it was $493M. Ranked #2933 of 3,112 in US market (top 94%), #1309 of 1,445 on NASDAQ (top 91%), #184 of 206 in Health Care Equipment & Services (top 89%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $338M | US#2,933/3,112 Sec#184/206 |
| Revenue | $86M | US#2,813/3,112 Sec#195/206 |
| Net Income | $-94M | US—/3,112 Sec—/206 |
| Total Assets | $639M | US#2,654/3,112 Sec#151/206 |
| Net Assets | $561M | US#2,175/3,112 Sec#112/206 |
| Value | ||
| P/B | 0.60x | US#99/3,112 Sec#6/206 |
| P/S | 3.92x | US#2,053/3,112 Sec#141/206 |
| FCF Yield | -27.94% | US—/3,112 Sec—/206 |
| Profitability | ||
| ROE | -16.77% | US#2,487/3,112 Sec#146/206 |
| ROA | -14.72% | US#2,717/3,112 Sec#164/206 |
| Op. Margin | -91.02% | US#2,819/3,112 Sec#199/206 |
| Revenue Growth | 4.57% | US#1,782/3,112 Sec#134/206 |
| Financial Health | ||
| Debt Ratio | 13.90% | US#161/3,112 Sec#10/206 |
| Total Debt | $29M | US#2,648/3,112 Sec#164/206 |
| FCF | $-94M | US#2,578/3,112 Sec#189/206 |
| Cash | $266M | US#1,512/3,112 Sec#83/206 |
| Current Ratio | 12.36x | US#205/3,112 Sec#5/206 |
| Performance | ||
| 1Y Return | -33.37% | US#2,814/3,112 Sec#183/206 |
| 1M Return | -5.12% | US#2,250/3,112 Sec#147/206 |
| From 52W High | -49.64% | US#2,777/3,112 Sec#180/206 |
| 1Y MDD | -56.30% | US#2,628/3,112 Sec#160/206 |
| Trading | ||
| Volume | 1,259,606 shares | US#1,283/3,112 Sec#83/206 |
| Trading Value | $1M | US#3,015/3,112 Sec#198/206 |
| Per Share | ||
| EPS | $-0.19 | US—/3,112 Sec—/206 |
| BPS | $1.10 | US#2,611/3,112 Sec#179/206 |